Thus, together with the data showing that the COMT polymorphism predicted placebo responses in patients with irritable bowel syndrome and depression [44], [45], these observations militate for a role of COMT in nocebo responses also for other physiological systems and diseases. Here, COMT is linked to depressive symptom measurement.